Business Potential30 Dec 2021 11:17
I'm just revisiting DMTR having sold out (at a loss) in Feb. I'm sorry for shareholders as this was well ramped in 1H 2020.
IMO the tech is good but has been slow to gain traction. This Korean contract will bring revenue of c.£500k pa, they have existing revenue/customers and are talking to 5 of the top ten pharma co's.
I will buy if the share goes near the placing price... for sure
DYOR